These are a group of rare genetic diseases that affect muscles and nerves. They are caused by changes in a specific gene (LMNA) and can lead to muscle weakness, heart problems, and other issues.
Every report comes from a Lived member, sent anonymously.
Have you had Implantable Cardioverter Defibrillators for Laminopathies?
Laminopathies are a family of rare genetic diseases caused by changes in one gene, LMNA. This gene makes lamin A and lamin C, proteins that form a supportive mesh just inside the envelope around each cell's nucleus. When these proteins are altered, cells that face a lot of mechanical stress or have specialized jobs, such as heart and skeletal muscle, fat tissue and nerves, can be damaged over time. The same gene produces very different conditions, which is why laminopathies are described as a group rather than a single disease. More than 15 have been described, falling into five broad types: heart muscle disease with rhythm problems (LMNA-related cardiomyopathy), muscular dystrophies such as Emery-Dreifuss muscular dystrophy, a form of fat loss called familial partial lipodystrophy (Dunnigan type), nerve disease (a form of Charcot-Marie-Tooth disease), and premature-aging syndromes such as Hutchinson-Gilford progeria. Features often overlap, and even the same gene change can look different from one person to the next. The heart is the most important thread running through many of these conditions. When a laminopathy affects the heart, it tends to disturb the heart's electrical system first, causing slow or irregular rhythms, and it carries a real risk of sudden death, sometimes before the heart's pumping strength has noticeably weakened.
Laminopathies are caused by a change (variant) in the LMNA gene, not by infection, lifestyle or anything a person or parent did. Most forms are autosomal dominant: one altered copy of the gene is enough, so a parent with the variant has a 50 percent chance of passing it to each child. Many cases, though, arise from a new variant in someone with no family history. This is true of nearly all Hutchinson-Gilford progeria and of roughly two thirds of LMNA-related Emery-Dreifuss muscular dystrophy. A few rarer forms need altered copies from both parents. Which condition develops depends partly on where in the gene the change sits and what kind of change it is, but researchers cannot yet fully explain why the same variant causes heart disease in one relative and muscle or fat problems in another. In LMNA heart disease, variants that stop the gene from producing a working protein tend to carry a higher rhythm risk, as do male sex and early signs of electrical disease.
Diagnosis usually starts with one of several recognizable patterns. One is early heart rhythm or conduction problems (delays or blocks in the electrical signal that sets the heartbeat), sometimes alongside heart muscle weakness, especially with a family history of sudden death. Others are joint stiffness with slowly progressive muscle weakness, an unusual distribution of body fat with diabetes or very high triglycerides, and a child with slowed growth and signs of premature aging. Genetic testing that finds a disease-causing LMNA variant confirms it. Because results can be hard to interpret, testing is best done with a genetic counselor or a specialty clinic. Once the diagnosis is made, a heart evaluation matters for most forms. This usually includes an electrocardiogram (ECG), a recording of the heart's electrical activity; extended rhythm monitoring with a wearable monitor; an echocardiogram (ultrasound of the heart) to measure ejection fraction, the share of blood the main pumping chamber pushes out with each beat (below about 50 percent is reduced); and often a cardiac MRI to look for scarring. Specialists can combine these findings with the type of variant to estimate a person's five-year risk of a dangerous rhythm. Relatives should be offered genetic testing, and those who carry the variant need regular heart checks, because carriers are often symptom-free in early adulthood and develop rhythm problems in their 30s or 40s.
There is no treatment that corrects the underlying gene change for most laminopathies, so care targets the problems each form causes and aims to prevent the most serious ones. It is usually coordinated across cardiology, neurology, endocrinology and genetics. For the heart, a pacemaker treats a slow heartbeat but does not prevent sudden death, so many people with LMNA heart disease are offered an implantable cardioverter-defibrillator (ICD), a small device under the skin that detects a dangerous rhythm and delivers a shock to reset it. European guidelines advise considering one when the estimated five-year risk is 10 percent or more and there is reduced pumping, a block in the heart's electrical conduction between the upper and lower chambers, or brief runs of fast abnormal rhythm from the lower chambers. An ICD can also deliver unnecessary shocks and does not slow heart-failure progression. When heart failure becomes advanced, early referral for a heart transplant is advised. Atrial fibrillation, an irregular rhythm in the upper chambers, raises the risk of stroke. Doctors usually decide on a blood thinner using a stroke-risk score based on age and conditions such as high blood pressure and diabetes, but in laminopathies a blood thinner is generally recommended even when that score is low. For the muscular forms, there is no specific medicine for the weakness. Physical therapy, stretching, braces and mobility aids help, and severe contractures (fixed tightening of joints) can sometimes be released surgically. For partial lipodystrophy, diabetes, high triglycerides, fatty liver and cholesterol are treated much as in the general population, with diet and physical activity as the foundation. Metreleptin (Myalept), a leptin-replacement injection approved in the US for generalized lipodystrophy, has been tried in severe partial cases, but its benefit there is not established. For Hutchinson-Gilford progeria, lonafarnib (Zokinvy), an oral capsule for people 12 months and older above a minimum body size, is approved to reduce the risk of death, and it is also approved for certain closely related progeria-like laminopathies. It does not apply to other laminopathies, and stomach upset such as vomiting and diarrhea is common.
The course depends heavily on the form. In LMNA heart disease, many people feel well for years. Electrical problems usually appear first, then pumping weakness, and the condition tends to progress, so lifelong cardiology follow-up with repeated rhythm monitoring and imaging is part of life. In the muscular dystrophies, joint stiffness and weakness usually worsen slowly over years, and mobility support may be needed. Heart involvement is expected by adulthood, so heart checks continue even when muscle symptoms are mild. Anesthesia and surgery need planning with teams who know the condition. In partial lipodystrophy, much of the work is long-term metabolic care, and sleep apnea and early artery disease are worth screening for. Progeria is a severe childhood disease in which hardening of the arteries leads to heart attack and stroke at a young age, while thinking and learning are not affected. Because the condition is inherited, families often face testing and planning decisions together. Genetic counseling and patient organizations can help with those conversations.
See a doctor about genetic testing and a heart evaluation if a close relative has a laminopathy, or if you have unexplained conduction problems or heart muscle weakness at a young age, especially with a family history of sudden death. Contact your care team promptly about near-fainting, new palpitations, a noticeably slow heartbeat, a single ICD shock after which you feel fine, or worsening breathlessness or leg swelling. If you faint (pass out), get emergency care the same day; call 911 if fainting comes with chest pain, a pounding or irregular heartbeat, or the person does not come round within a couple of minutes. Call 911 for several ICD shocks in a short time or a shock followed by feeling unwell, fainting, chest pain or trouble breathing. If someone collapses and is unresponsive, call 911 and start CPR.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Laminopathies is like, what's helped you, or ask the community a question.